Experts have recommended that, for patients with cancer-related pain who are using nonmedical stimulants, opioids should be continued, monitoring should be increased, and tapering should be avoided.
Pharmaceutical experts review ocular adverse effects related to antibody-drug conjugates.
Ocular side effects of immune checkpoint inhibitors are considered rare but may be underreported.
The FDA has issued a complete response letter related to the new drug application for avasopasem manganese to treat radiotherapy-induced severe oral mucositis in patients with head and neck cancer undergoing standard treatment.
A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.
Researchers compared a turmeric mouthwash to benzydamine mouthwash in patients with head and neck cancer.
The occurrence and duration of chemotherapy-induced nausea and vomiting (CINV) during the first cycle of chemotherapy predict CINV recurrence in later cycles, a study suggests.
Acupuncture can reduce aromatase inhibitor-related joint pain in women with early breast cancer, a study suggests.
ASCO and SIO issued a joint guideline on the use of integrative medicine for pain management in oncology.
Researchers sought to measure real-world adherence to patient-reported outcome monitoring as a cancer care metric.
